Public health effectiveness of the FDA 510(k) clearance process : balancing patient safety and innovation : workshop report / / Theresa Wizemann, editor ; Committee on the Public Health Effectiveness of the FDA 510(k) clearance process, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.

Saved in:
Bibliographic Details
:
TeilnehmendeR:
Year of Publication:2011
Language:English
Online Access:
Physical Description:xiv, 118 p. :; ill. (some color)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 01895nam a2200373Ia 4500
001 5003378791
003 MiAaPQ
005 20200520144314.0
006 m o d |
007 cr cn|||||||||
008 101112s2011 dcua sb 100 0 eng d
020 |z 9780309162067 
035 |a (MiAaPQ)5003378791 
035 |a (Au-PeEL)EBL3378791 
035 |a (CaPaEBR)ebr10478243 
035 |a (CaONFJC)MIL313497 
035 |a (OCoLC)923283535 
040 |a MiAaPQ  |c MiAaPQ  |d MiAaPQ 
050 4 |a RA399.A3  |b P83 2011 
245 0 0 |a Public health effectiveness of the FDA 510(k) clearance process  |h [electronic resource] :  |b balancing patient safety and innovation : workshop report /  |c Theresa Wizemann, editor ; Committee on the Public Health Effectiveness of the FDA 510(k) clearance process, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies. 
246 3 |a FDA 510(k) clearance process 
260 |a Washington, D.C. :  |b National Academies Press,  |c c2011. 
300 |a xiv, 118 p. :  |b ill. (some color) 
504 |a Includes bibliographical references. 
533 |a Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. 
610 1 0 |a United States.  |b Food and Drug Administration. 
650 0 |a Public health  |x Equipment and supplies  |x Standards  |z United States  |v Congresses. 
650 0 |a Public health  |z United States  |v Congresses. 
655 4 |a Electronic books. 
700 1 |a Wizemann, Theresa M. 
710 2 |a Institute of Medicine (U.S.).  |b Board on Population Health and Public Health Practice. 
710 2 |a Institute of Medicine (U.S.).  |b Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process. 
710 2 |a ProQuest (Firm) 
856 4 0 |u https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3378791  |z Click to View